Nadine Beauger, Chief Executive Officer of IRICoR, participated, this Monday, to the 2nd edition of the International Congress on Personalized Health Care (ICPHC2018) organized by The Quebec Network for Personalized Health Care (QNPHC) to present the innovative business model of IRICoR at the « Innovative Technologies in “OMICS” Applications » session.
As Université de Montréal’s drug discovery and project maturation cluster, IRICoR brings together a team of expert working to accelerate the discovery of drugs. In recent years, new alliances between academia and the pharmaceutical industry have emerged to enable an avant-garde transformation of research into innovative therapies.
For more information on the program (only in french)